Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Am Heart J
    February 2024
  1. ROYER P, Bjornson E, Adiels M, Alvez MB, et al
    Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention.
    Am Heart J. 2024 Feb 5:S0002-8703(24)00020-6. doi: 10.1016/j.ahj.2024.
    >> Share

  2. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Wildi K, et al
    External validation of the 0/1h-algorithm and derivation of a 0/2h-algorithm using a new point-of-care Hs-cTnI assay.
    Am Heart J. 2024;268:104-113.
    >> Share

  3. KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al
    TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic Valve Stenosis and M
    Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024.
    >> Share

    January 2024
  4. CEVIK E, Tas A, Demirtakan ZG, Damman P, et al
    Intracoronary Electrocardiogram Detects Coronary Microvascular Dysfunction and Ischemia in Patients with No Obstructive Coronary Arteries Disease.
    Am Heart J. 2024 Jan 24:S0002-8703(24)00010-3. doi: 10.1016/j.ahj.2024.
    >> Share

  5. ASHWAT E, Brown JA, Yousef S, Ahmad D, et al
    Radial Artery versus Right Internal Mammary Artery as a Second Conduit during Coronary Artery Bypass Grafting.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00015-2. doi: 10.1016/j.ahj.2024.
    >> Share

  6. MAQSOOD MH, Nguyen R, Chang R, Kundi H, et al
    Unfavorable social determinants of health and mortality risk by cardiovascular disease status: Findings from a National Study of United States Adults.
    Am Heart J. 2024;267:95-100.
    >> Share

    December 2023
  7. BOHULA EA, Marston NA, Ruzza A, Murphy SA, et al
    Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial.
    Am Heart J. 2023 Dec 29:S0002-8703(23)00349-6. doi: 10.1016/j.ahj.2023.
    >> Share

  8. SIREN M, Leivo J, Anttonen E, Jolly SS, et al
    The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of the Randomized TOTAL Trial.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
    >> Share

  9. MAZHAR F, Hjemdahl P, Sjolander A, Kahan T, et al
    Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00351-4. doi: 10.1016/j.ahj.2023.
    >> Share

  10. DILLEN DMM, Vlaar PJ, Vermeer AJE, Paradies V, et al
    Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
    Am Heart J. 2023;266:168-175.
    >> Share

    November 2023
  11. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    >> Share

  12. SALAHUDDIN T, Hebbe A, Daus M, Essien UR, et al
    Trends and Site-level Variation of Novel Cardiovascular Medication Utilization among Patients Admitted for Heart Failure or Coronary Artery Disease in the US Veterans Affairs System: 2017-2021.
    Am Heart J. 2023 Nov 11:S0002-8703(23)00318-6. doi: 10.1016/j.ahj.2023.
    >> Share

  13. SLAVIN SD, Berman AN, Gaba P, Hoshi RA, et al
    Influenza Vaccination and Use of Lipid Lowering Therapies in Adults with Atherosclerotic Cardiovascular Disease: An Analysis of the Behavioral Risk Factor Surveillance System (BRFSS): Influenza Vaccination and Cholesterol Medication Use.
    Am Heart J. 2023 Nov 11:S0002-8703(23)00316-2. doi: 10.1016/j.ahj.2023.
    >> Share

    October 2023
  14. THOMAS A, O'Connell NS, Douglas E, Hatcher S, et al
    Cardiovascular Impact of Near Complete Estrogen Deprivation in Premenopausal Women with Breast Cancer: The CROWN Study.
    Am Heart J. 2023 Oct 25:S0002-8703(23)00300-9. doi: 10.1016/j.ahj.2023.
    >> Share

  15. BAINEY KR, Wood DA, Bossard M, Campo G, et al
    Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
    Am Heart J. 2023 Oct 21:S0002-8703(23)00297-1. doi: 10.1016/j.ahj.2023.
    >> Share

  16. OKAMI Y, Arima H, Kondo K, Hexun Z, et al
    The gut microbiota and coronary artery calcification in Japanese men.
    Am Heart J. 2023 Oct 5:S0002-8703(23)00282-X. doi: 10.1016/j.ahj.2023.
    >> Share

    September 2023
  17. FLETT A, Cebula A, Nicholas Z, Adam R, et al
    Rationale and study protocol for the BRITISH randomised trial (Using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with Non-Ischaemic Cardiomyopathy and
    Am Heart J. 2023 Sep 28:S0002-8703(23)00281-8. doi: 10.1016/j.ahj.2023.
    >> Share

  18. NICHOLLS SJ, Bhatt DL, Buse JB, Prato SD, et al
    Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics.
    Am Heart J. 2023 Sep 25:S0002-8703(23)00280-6. doi: 10.1016/j.ahj.2023.
    >> Share

  19. PUYMIRAT E, Soulat G, Fayol A, Mousseaux E, et al
    Rationale and Design of the Direct Oral Anticoagulants for Prevention of Left Ventricular Thrombus after Anterior Acute Myocardial Infarction (APERITIF) trial.
    Am Heart J. 2023 Sep 14:S0002-8703(23)00278-8. doi: 10.1016/j.ahj.2023.
    >> Share

  20. WANG KL, Meah MN, Bularga A, Oatey K, et al
    Early Computed Tomography Coronary Angiography and Preventative Treatment in Patients with Suspected Acute Coronary Syndrome A secondary analysis of the RAPID-CTCA trial.
    Am Heart J. 2023 Sep 12:S0002-8703(23)00275-2. doi: 10.1016/j.ahj.2023.
    >> Share

  21. YAO H, Cottin Y, Chague F, Maza M, et al
    Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
    Am Heart J. 2023 Sep 11:S0002-8703(23)00273-9. doi: 10.1016/j.ahj.2023.
    >> Share

    August 2023
  22. DELMAS C, Laine M, Schurtz G, Roubille F, et al
    Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock.
    Am Heart J. 2023 Aug 30:S0002-8703(23)00265-X. doi: 10.1016/j.ahj.2023.
    >> Share

  23. BRADLEY CP, Orchard V, McKinley G, Heggie R, et al
    The Coronary Microvascular Angina Cardiovascular Magnetic Resonance Imaging Trial: Rationale and Design.
    Am Heart J. 2023 Aug 30:S0002-8703(23)00264-8. doi: 10.1016/j.ahj.2023.
    >> Share

  24. JAMES S, Erlinge D, Storey RF, McGuire DK, et al
    Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00207-7. doi: 10.1016/j.ahj.2023.
    >> Share

  25. AGNELLO F, Finocchiaro S, Laudani C, Legnazzi M, et al
    A Review of Polypills for the Prevention of Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00211-9. doi: 10.1016/j.ahj.2023.
    >> Share

  26. NAAMI R, Tashtish N, Neeland IJ, Katz J, et al
    Coronary Artery Calcium Scoring for Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00209-0. doi: 10.1016/j.ahj.2023.
    >> Share

  27. LI Q, Ding Y, Chen Q, Tang Y, et al
    Diagnostic Performance of a Novel Automated CT-derived FFR Technology in Detecting Hemodynamically Significant Coronary Artery Stenoses: A Multicenter Trial in China.
    Am Heart J. 2023 Aug 21:S0002-8703(23)00206-5. doi: 10.1016/j.ahj.2023.
    >> Share

  28. NEWMAN JD, Anthopolos R, Ruggles KV, Cornwell M, et al
    Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials: Biomarkers and risk prediction in stable coronary artery disease. A post-hoc secondary analysis from the ISCHEMIA randomized clinical trial bioreposi
    Am Heart J. 2023 Aug 19:S0002-8703(23)00204-1. doi: 10.1016/j.ahj.2023.
    >> Share

  29. JENTZER JC, Watanabe A, Kuno T, Bangalore S, et al
    Network meta-analysis of temporary mechanical circulatory support in acute myocardial infarction cardiogenic shock.
    Am Heart J. 2023 Aug 15:S0002-8703(23)00199-0. doi: 10.1016/j.ahj.2023.
    >> Share

  30. PICCOLO R, Calabro P, Varricchio A, Baldi C, et al
    Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI.
    Am Heart J. 2023 Aug 10:S0002-8703(23)00188-6. doi: 10.1016/j.ahj.2023.
    >> Share

  31. RIVERA FB, Cha SW, Ansay MFM, Talino MKV, et al
    Cardiovascular Disease in Filipino American Men and Women: A 2023 Update.
    Am Heart J. 2023 Aug 4:S0002-8703(23)00186-2. doi: 10.1016/j.ahj.2023.
    >> Share

  32. PARLOW S, Santo PD, Sterling LH, Goodliffe L, et al
    Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial.
    Am Heart J. 2023;262:83-89.
    >> Share

    July 2023
  33. ICHIKAWA K, Hansen S, Manubolu VS, Pourafkari L, et al
    Prognostic value of Coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the Multi-Ethnic Study of Atherosclerosis.
    Am Heart J. 2023 Jul 28:S0002-8703(23)00180-1. doi: 10.1016/j.ahj.2023.
    >> Share

  34. VAN DER SANGEN NMR, Kucuk IT, Sivanesan S, Appelman Y, et al
    Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients: Rationale and Design of the LEGACY study.
    Am Heart J. 2023 Jul 28:S0002-8703(23)00183-7. doi: 10.1016/j.ahj.2023.
    >> Share

  35. WILLIAMS BA, Rajpura J, Paprocki YM, Kumar N, et al
    Temporal Trends in Cardiovascular Outcomes and Costs Among Patients with Type 2 Diabetes.
    Am Heart J. 2023 Jul 27:S0002-8703(23)00185-0. doi: 10.1016/j.ahj.2023.
    >> Share

  36. MATASIC DS, Blumenthal RS, Fonarow GC, Gulati M, et al
    Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention.
    Am Heart J. 2023 Jul 20:S0002-8703(23)00176-X. doi: 10.1016/j.ahj.2023.
    >> Share

  37. OSERAN AS, Dong H, Wadhera RK
    Cardiovascular Hospitalizations for Medicare Advantage Beneficiaries in the United States, 2009 to 2019.
    Am Heart J. 2023 Jul 12:S0002-8703(23)00174-6. doi: 10.1016/j.ahj.2023.
    >> Share

  38. PARK S, Rha SW, Choi BG, Kim W, et al
    Efficacy and Safety of Cilostazol-Based Triple Antiplatelet Therapy Compared with Clopidogrel-Based Dual Antiplatelet Therapy in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter, Rando
    Am Heart J. 2023 Jul 3:S0002-8703(23)00172-2. doi: 10.1016/j.ahj.2023.
    >> Share

  39. ARAKI T, Kondo T, Imaizumi T, Sumita Y, et al
    Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support.
    Am Heart J. 2023;261:109-123.
    >> Share

    June 2023
  40. LI C, Eikelboom JW, Zhong Z, Zhang X, et al
    Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial.
    Am Heart J. 2023 Jun 25:S0002-8703(23)00168-0. doi: 10.1016/j.ahj.2023.
    >> Share

  41. OSMANLLIU E, Kalwani NM, Parameswaran V, Qureshi L, et al
    Sociodemographic disparities in the use of cardiovascular ambulatory care and telemedicine during the COVID-19 pandemic.
    Am Heart J. 2023 Jun 25:S0002-8703(23)00166-7. doi: 10.1016/j.ahj.2023.
    >> Share

  42. GRAY MP, Berman Y, Botta G, Grieve SM, et al
    Incorporating a Polygenic Risk Score-Triaged Coronary Calcium Score into Cardiovascular Disease Examinations to Identify SubClinicAL coronAry arTEry Disease (ESCALATE): Protocol for a Prospective, Non-Randomised Implementation Trial.
    Am Heart J. 2023 Jun 24:S0002-8703(23)00167-9. doi: 10.1016/j.ahj.2023.
    >> Share

  43. REDDY KP, Eberly LA, Julien HM, Giri J, et al
    Association between Racial Residential Segregation and Black-White Disparities in Cardiovascular Disease Mortality.
    Am Heart J. 2023 Jun 24:S0002-8703(23)00165-5. doi: 10.1016/j.ahj.2023.
    >> Share

  44. LOPES RD, de Barros E Silva PGM, Filho CRH, Cavalvante MA, et al
    The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
    Am Heart J. 2023 Jun 15:S0002-8703(23)00162-X. doi: 10.1016/j.ahj.2023.
    >> Share

  45. WENG Z, Zhao C, Qin Y, Liu C, et al
    Peripheral atherosclerosis in acute coronary syndrome patients with plaque rupture versus plaque erosion: A prospective coronary optical coherence tomography and peripheral ultrasound study.
    Am Heart J. 2023 Jun 14:S0002-8703(23)00161-8. doi: 10.1016/j.ahj.2023.
    >> Share

  46. SEGUCHI M, Aytekin A, Steiger L, Nicol P, et al
    Near-infrared Spectroscopy-Intravascular Ultrasound to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation (The IMPACTavi registry): Design and Rationale.
    Am Heart J. 2023 Jun 12:S0002-8703(23)00159-X. doi: 10.1016/j.ahj.2023.
    >> Share

  47. GUPTA K, Mehta H, Kim H, Stebbins A, et al
    Comparison of the effectiveness and safety of two aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: a subgroup analysis of ADAPTABLE.
    Am Heart J. 2023 Jun 6:S0002-8703(23)00145-X. doi: 10.1016/j.ahj.2023.
    >> Share

  48. BUJAK K, Vidal-Cales P, Gabani R, Rinaldi R, et al
    Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00141-2. doi: 10.1016/j.ahj.2023.
    >> Share

  49. GONZALEZ-DEL-HOYO M, Rossello X, Peral V, Pocock S, et al
    Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: insights from an international cohort of 23,489 patients with acute coronary syndrome.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00139-4. doi: 10.1016/j.ahj.2023.
    >> Share

  50. AHN JM, Kang DY, Lee PH, Ahn YK, et al
    Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque: Rationale and Design of the Randomized, Controlled PREVENT Trial.
    Am Heart J. 2023 Jun 2:S0002-8703(23)00134-5. doi: 10.1016/j.ahj.2023.
    >> Share

  51. WANG X, Guo R, Guo Y, Guo Q, et al
    Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI.
    Am Heart J. 2023;260:9-17.
    >> Share

    May 2023
  52. ATALLAH J, Chiha T, Chen C, Siller-Matula JM, et al
    Clinical Outcomes Associated with Type II Myocardial Infarction Caused by Bleeding.
    Am Heart J. 2023 May 16:S0002-8703(23)00119-9. doi: 10.1016/j.ahj.2023.
    >> Share

  53. SHAH NP, Peterson ED, Page C, Blanco R, et al
    Generalizability of an EHR-Network Dataset to the United States for Cardiovascular Disease Conditions: Comparison of Cerner Real World Data with the National Inpatient Sample.
    Am Heart J. 2023 May 15:S0002-8703(23)00120-5. doi: 10.1016/j.ahj.2023.
    >> Share

  54. HANER JD, Rohla M, Losdat S, Iglesias JF, et al
    Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials.
    Am Heart J. 2023 May 14:S0002-8703(23)00115-1. doi: 10.1016/j.ahj.2023.
    >> Share

  55. WOODWARD G, Bajre M, Bhattacharyya S, Breen M, et al
    PROTEUS Study: A Prospective Randomised Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography.
    Am Heart J. 2023 May 14:S0002-8703(23)00114-X. doi: 10.1016/j.ahj.2023.
    >> Share

  56. ANANTH CV, Rutherford C, Rosenfeld EB, Brandt JS, et al
    Epidemiologic Trends and Risk Factors Associated with the Decline in Mortality from Coronary Heart Disease in the United States, 1990-2019.
    Am Heart J. 2023 May 11:S0002-8703(23)00117-5. doi: 10.1016/j.ahj.2023.
    >> Share

  57. ARNOLD SV, Gosch K, Kosiborod M, Wong ND, et al
    Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.
    Am Heart J. 2023 May 8:S0002-8703(23)00112-6. doi: 10.1016/j.ahj.2023.
    >> Share

    April 2023
  58. LI N, Chen R, Li J, Zhao X, et al
    Prognostic significance of serial NT-proBNP levels in patients with acute myocardial infarction: A prospective study.
    Am Heart J. 2023 Apr 26:S0002-8703(23)00110-2. doi: 10.1016/j.ahj.2023.
    >> Share

  59. BACK M, Leosdottir M, Ekstrom M, Hambraeus K, et al
    The Remote Exercise SWEDEHEART study - Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT).
    Am Heart J. 2023 Apr 25:S0002-8703(23)00109-6. doi: 10.1016/j.ahj.2023.
    >> Share

  60. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
    Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
    Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
    >> Share

  61. CHIUSOLO S, Bork CS, Gentile F, Lundbye-Christensen S, et al
    Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction.
    Am Heart J. 2023 Apr 20:S0002-8703(23)00089-3. doi: 10.1016/j.ahj.2023.
    >> Share

  62. BROWN JY, Drakeley S, Duncan M, Knapp WP, et al
    Moderate Intensity Exercise in Pregnant Patients with Cardiovascular Disease: A Pilot Study.
    Am Heart J. 2023 Apr 16:S0002-8703(23)00090-X. doi: 10.1016/j.ahj.2023.
    >> Share

  63. HUANG D, Gong Y, Fan Y, Zheng B, et al
    Coronary Angiography-Derived Index for Assessing Microcirculatory Resistance in Patients with Non-Obstructed Vessels: The FLASH IMR Study.
    Am Heart J. 2023 Apr 11:S0002-8703(23)00088-1. doi: 10.1016/j.ahj.2023.
    >> Share

  64. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    >> Share

  65. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    >> Share

  66. AUER J, Lamm G
    Blood pressure control in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:186-189.
    >> Share

  67. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
    Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
    Am Heart J. 2023;258:49-59.
    >> Share

    March 2023
  68. CHA JJ, Hong SJ, Kim JH, Lim S, et al
    Effect of rosuvastatin 20mg versus rosuvastatin 5mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00064-9. doi: 10.1016/j.ahj.2023.
    >> Share

  69. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    >> Share

  70. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    A Randomized Controlled Trial of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients with Elevated Risk for Cardiovascular Disease: Rationale and Design of the BE ACTIVE Study.
    Am Heart J. 2023 Mar 2:S0002-8703(23)00048-0. doi: 10.1016/j.ahj.2023.
    >> Share

  71. DEFILIPPIS AP, Lidani KCF, Nam Y, Trainor PJ, et al
    Risk Factor Associations with Individual Myocardial Infarction Subtypes and Acute Non-Ischemic Myocardial Injury in the Multi-Ethnic Study of Atherosclerosis (MESA): Design and Rationale.
    Am Heart J. 2023 Mar 1:S0002-8703(23)00047-9. doi: 10.1016/j.ahj.2023.
    >> Share

    February 2023
  72. CASTELIJNS MC, Hageman SHJ, Teraa M, van der Meer MG, et al
    External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.
    Am Heart J. 2023 Feb 23:S0002-8703(23)00046-7. doi: 10.1016/j.ahj.2023.
    >> Share

  73. DAVIDSON SJ, Roncalli J, Surder D, Corti R, et al
    Microvascular Obstruction Identifies a Subgroup of Patients Who Benefit from Stem Cell Therapy Following ST-Elevation Myocardial Infarction.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00037-6. doi: 10.1016/j.ahj.2023.
    >> Share

  74. SCOCCIA A, Byrne RA, Banning AP, Landmesser U, et al
    Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization. Rationale and study design of the prospective randomized FAST III Trial.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00036-4. doi: 10.1016/j.ahj.2023.
    >> Share

  75. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    >> Share

  76. KAUL U, Arambam P, Sinha SK, Abhaichand R, et al
    Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
    Am Heart J. 2023;256:128-138.
    >> Share

    January 2023
  77. SILVAIN J, Cayla G, Ferrari E, Range G, et al
    betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
    Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
    >> Share

  78. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    >> Share

  79. BHATT AS, Daniels LB, de Lemos J, Goodrich E, et al
    Multi-Marker Risk Assessment in Patients Hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Am Heart J. 2023 Jan 17:S0002-8703(22)00334-9. doi: 10.1016/j.ahj.2022.
    >> Share

  80. CHOUAIRI F, Pinsker B, Fudim M, Miller PE, et al
    Trends in Outcomes and Resource Utilization for Acute Myocardial Infarction Admissions During the COVID-19 Pandemic.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00012-1. doi: 10.1016/j.ahj.2023.
    >> Share

  81. BRANCH KRH, Probstfield JL, Bosch J, Bhatt DL, et al
    Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00015-7. doi: 10.1016/j.ahj.2023.
    >> Share

  82. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    >> Share

  83. SPAULDING C, Krackhardt F, Bogaerts K, Urban P, et al
    Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00010-8. doi: 10.1016/j.ahj.2023.
    >> Share

  84. MOLLER JE, Gerke O
    Danish-German cardiogenic shock trial-DanGer shock: Trial design update.
    Am Heart J. 2023;255:90-93.
    >> Share

  85. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Nestelberger T, et al
    Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm.
    Am Heart J. 2023;255:58-70.
    >> Share

    December 2022
  86. DELEWI R, Vogel RF, Wilschut JM, Lemmert ME, et al
    Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00335-0. doi: 10.1016/j.ahj.2022.
    >> Share

  87. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    >> Share

  88. EKMEJIAN A, Allahwala U, Ward M, Bhindi R, et al
    Impact of coronary disease patterns, anatomical factors, micro-vascular disease and non-coronary cardiac factors on invasive coronary physiology.
    Am Heart J. 2022 Dec 9:S0002-8703(22)00327-1. doi: 10.1016/j.ahj.2022.
    >> Share

  89. LIU J, Wang B, Li Y, Yan X, et al
    Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
    >> Share

  90. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    >> Share

  91. ANTHOPOLOS R, Maron DJ, Bangalore S, Reynolds HR, et al
    ISCHEMIA-EXTEND studies: Rationale and design.
    Am Heart J. 2022;254:228-233.
    >> Share

  92. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    >> Share

    November 2022
  93. RAMUNDDAL T, Holck EN, Karim S, Eftekhari A, et al
    International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions with Myocardial Ischemia - ISCHEMIA-CTO Trial - Rationale and Design.
    Am Heart J. 2022 Nov 21:S0002-8703(22)00298-8. doi: 10.1016/j.ahj.2022.
    >> Share

  94. CARSON JL, Brooks MM, Chaitman BR, Alexander JH, et al
    Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial.
    Am Heart J. 2022 Nov 20:S0002-8703(22)00297-6. doi: 10.1016/j.ahj.2022.
    >> Share

  95. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    >> Share

  96. SNAVELY AC, Paradee BE, Ashburn NP, Allen BR, et al
    Derivation and validation of a high sensitivity troponin-T HEART pathway.
    Am Heart J. 2022;256:148-157.
    >> Share

  97. SPIRITO A, Sticchi A, Praz F, Grani C, et al
    Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes.
    Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00291.
    >> Share

  98. DE CARVALHO FPC, Hueb W, Lima EG, Rezende PC, et al
    Cardiovascular Events in Patients with Coronary Artery Disease with and Without Myocardial Ischemia: Long-Term Follow-Up.
    Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00293.
    >> Share

  99. KOIVUNEN M, Tynkkynen J, Oksala N, Eskola M, et al
    Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction.
    Am Heart J. 2022 Nov 13. pii: S0002-8703(22)00290.
    >> Share

  100. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
    Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00289.
    >> Share

  101. CORNELISSEN A, Guo L, Neally SJ, Kleinberg L, et al
    Relationships Between Neighborhood Disadvantage and Cardiovascular Findings at Autopsy in Subjects with Sudden Death.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00284.
    >> Share

  102. NISHIZAKI Y, Miyauchi K, Iwata H, Inoue T, et al
    Study Protocol and Baseline Characteristics of Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, The Combination of a Randomized Control Trial and an Observational Bioma
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00282.
    >> Share

  103. NOUHRAVESH N, Strange JE, Tonnesen J, Holt A, et al
    Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study.
    Am Heart J. 2022 Nov 9. pii: S0002-8703(22)00281.
    >> Share

  104. YEN TH, Yen JS
    Chelation trial in patients with cardiovascular disease.
    Am Heart J. 2022 Nov 3. pii: S0002-8703(22)00279.
    >> Share

  105. GARCIA H, Springer B, Vengrenyuk A, Krishnamoorthy P, et al
    Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project.
    Am Heart J. 2022;253:30-38.
    >> Share

    October 2022
  106. FROBERT O, Gotberg M, Erlinge D, Akhtar Z, et al
    Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial.
    Am Heart J. 2022 Oct 21. pii: S0002-8703(22)00198.
    >> Share

  107. GASPARDONE C, Romagnolo D, Fasolino A, Falasconi G, et al
    A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Oct 19. pii: S0002-8703(22)00272.
    >> Share

  108. WOLNY R, Niedziela J, Desperak P, Kwiecinski J, et al
    Infarct-related artery and long-term mortality following recurrent ST-segment elevation myocardial infarction. Insights from a Polish nationwide registry.
    Am Heart J. 2022 Oct 12. pii: S0002-8703(22)00200.
    >> Share

  109. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
    On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
    >> Share

  110. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    >> Share

  111. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    >> Share

  112. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    >> Share

  113. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    >> Share

  114. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    The trial to assess chelation therapy 2 (TACT2): Rationale and design.
    Am Heart J. 2022;252:1-11.
    >> Share

    September 2022
  115. DESAI RJ, Glynn RJ, Everett BM, Schneeweiss S, et al
    Comparative effectiveness of empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
    Am Heart J. 2022 Sep 20. pii: S0002-8703(22)00193.
    >> Share

  116. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    >> Share

  117. KAPUR NK, Kim RJ, Moses JW, Stone GW, et al
    Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.
    Am Heart J. 2022 Sep 1. pii: S0002-8703(22)00184.
    >> Share

    August 2022
  118. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    >> Share

  119. KRANENDONK J, Willems LH, Vijver-Coppen RV, Coenen M, et al
    CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD).
    Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00163.
    >> Share

  120. UKAH UV, Li X, Wei SQ, Healy-Profitos J, et al
    Black-White disparity in severe cardiovascular maternal morbidity: a systematic review and meta-analysis.
    Am Heart J. 2022 Aug 6. pii: S0002-8703(22)00162.
    >> Share

  121. SHAVADIA JS, Wilson J, Edmonston D, Platt A, et al
    Corrigendum to "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease" [Am Heart J (2021) 231:36-44].
    Am Heart J. 2022 Aug 4. pii: S0002-8703(22)00142.
    >> Share

    July 2022
  122. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    >> Share

  123. SHAH N, Ghazi L, Yamamoto Y, Martin M, et al
    Rationale and Design of a Pragmatic Trial Aimed at Improving Treatment of Hyperlipidemia in Outpatients with Very High Risk Atherosclerotic Cardiovascular Disease: A PRagmatic Trial Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-L
    Am Heart J. 2022 Jul 13. pii: S0002-8703(22)00146.
    >> Share

  124. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
    Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
    >> Share

  125. AKINYELURE OP, Colantonio LD, Chaudhary NS, Jaeger BC, et al
    Inflammation biomarkers and incident coronary heart disease: The Reasons for Geographic and Racial Differences in Stroke Study.
    Am Heart J. 2022 Jul 7. pii: S0002-8703(22)00144.
    >> Share

    June 2022
  126. MOHEBI R, McCarthy CP, Gaggin HK, Kimmenade RRJV, et al
    Inflammatory Biomarkers and Risk of Cardiovascular Events in Patients Undergoing Coronary Angiography.
    Am Heart J. 2022 Jun 23. pii: S0002-8703(22)00128.
    >> Share

  127. DIXON D, Patel J, Spence R, Talasaz A, et al
    Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
    Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
    >> Share

  128. VOGEL RF, Delewi R, Wilschut JM, Lemmert ME, et al
    Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial.
    Am Heart J. 2022 Jun 4. pii: S0002-8703(22)00116.
    >> Share

  129. REIFFEL JA
    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.
    >> Share

  130. ISLEK D, Alonso A, Rosamond W, Kucharska-Newton A, et al
    Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC Community Surveillance Study.
    Am Heart J. 2022 Jun 1. pii: S0002-8703(22)00114.
    >> Share

    May 2022
  131. MAZHAR F, Hjemdahl P, Clase CM, Johnell K, et al
    Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00115.
    >> Share

  132. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    >> Share

  133. KHAN MINHAS AM, Ijaz SH, Javed N, Sheikh AB, et al
    National Trends and Disparities in Statin Use for Ischemic Heart Disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00109.
    >> Share

  134. OMEROVIC E, Erlinge D, Koul S, Frobert O, et al
    Rationale and Design of Switch Swedeheart: A Registry-Based, Stepped-Wedge, Cluster-Randomized, Open-Label Multicenter Trial to Compare Prasugrel and Ticagrelor for Treatment of Patients with Acute Coronary Syndrome.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00112.
    >> Share

  135. BLUMENTHAL JA, Smith PJ, Jiang W, Hinderliter A, et al
    Longer Term Benefits of Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: Six Month Follow-up of the UNWIND Randomized Clinical Trial.
    Am Heart J. 2022 May 21. pii: S0002-8703(22)00106.
    >> Share

  136. NEWMAN JD, Douglas PS, Zhbannikov I, Ferencik M, et al
    Associations of a Polygenic Risk Score with Coronary Artery Disease Phenotypes in The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial.
    Am Heart J. 2022 May 20. pii: S0002-8703(22)00104.
    >> Share

  137. HARRINGTON J, Udell JA, Jones WS, Anker SD, et al
    Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial.
    Am Heart J. 2022 May 17. pii: S0002-8703(22)00095.
    >> Share

  138. CANTOR WJ, Tan M, Berwanger O, Lavi S, et al
    Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00089.
    >> Share

  139. O'DONOGHUE ML, Lopez JAG, Knusel B, Gencer B, et al
    Study Design and Rationale for the OCEAN(a)-DOSE (Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction-DOSE Finding Study) Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00086.
    >> Share

  140. FORREST IS, Chan L, Chaudhary K, Saha A, et al
    Genome-First Recall of Healthy Individuals by Polygenic Risk Score Reveals Differences in Coronary Artery Calcium.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00081.
    >> Share

  141. DENOBLE AE, Goldstein SA, Wein MLE, Grotegut CA, et al
    Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00084.
    >> Share

  142. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    >> Share

    April 2022
  143. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    >> Share

  144. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    >> Share

    March 2022
  145. UDELL JA, Lu D, Bagai A, Dodson JA, et al
    Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction.
    Am Heart J. 2022 Mar 23. pii: S0002-8703(22)00056.
    >> Share

  146. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
    Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
    Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
    >> Share

  147. ERQOU S, Papaila A, Halladay C, Ge A, et al
    Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Mar 19. pii: S0002-8703(22)00054.
    >> Share

  148. GENEREUX P, Chernin G, Assali AR, Peruga JZ, et al
    Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.
    Am Heart J. 2022 Mar 16. pii: S0002-8703(22)00052.
    >> Share

  149. GENEREUX P, Kirtane AJ, Kandzari DE, Armstrong EJ, et al
    Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.
    Am Heart J. 2022 Mar 11. pii: S0002-8703(22)00051.
    >> Share

  150. TIAN X, Zuo Y, Chen S, Meng X, et al
    Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults.
    Am Heart J. 2022 Mar 3. pii: S0002-8703(22)00047.
    >> Share

  151. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
    The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
    Am Heart J. 2022;245:136-148.
    >> Share

    February 2022
  152. VERMA KP, Marwick T, Duarte C, Meikle P, et al
    Use of Coronary Computed Tomography or Polygenic Risk Scores to Prompt Action to Reduce Coronary Artery Disease Risk: The CAPAR-CAD Trial.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00040.
    >> Share

  153. COUCH SC, Helsley RN, Siegel FU, Saelens BE, et al
    Design and Rationale for the Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction Trial.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00044.
    >> Share

  154. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    >> Share

  155. CHO MS, Kang DY, Oh YS, Lee CH, et al
    Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
    >> Share

  156. SIDHU MS, Alexander KP, Huang Z, O'Brien SM, et al
    Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00026.
    >> Share

  157. HASSAN R, Riehl-Tonn V, Dumanski SM, Lyons KJ, et al
    Female Sex-Specific Cardiovascular Risk Factors and Heart Failure Practice Guidelines.
    Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00008.
    >> Share

  158. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
    Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
    Am Heart J. 2022;244:125-134.
    >> Share

    January 2022
  159. JAIN B, Bajaj SS, Paguio JA, Yao JS, et al
    Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Jan 27. pii: S0002-8703(22)00011.
    >> Share

  160. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    >> Share

  161. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
    Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial.
    Am Heart J. 2022 Jan 20. pii: S0002-8703(22)00009.
    >> Share

  162. TIES D, van Dorp P, Pundziute G, van der Aalst CM, et al
    Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
    Am Heart J. 2022 Jan 13. pii: S0002-8703(22)00005.
    >> Share

  163. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    >> Share

  164. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
    Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
    >> Share

  165. HARIRI E, Kassas I, Hammoud MA, Hansra B, et al
    Same Day Discharge Following Non-elective PCI for Non-ST Elevation Acute Coronary Syndromes.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00497.
    >> Share

  166. HARA H, Serruys PW, O'Leary N, Gao C, et al
    Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
    >> Share

  167. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
    Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
    Am Heart J. 2022;243:187-200.
    >> Share

    December 2021
  168. RIFAI MA, Mahtta D, Ramsey DJ, Lee MT, et al
    nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00480.
    >> Share

  169. HSU B, Carcel C, Wang X, Peters SAE, et al
    Erratum to "Sex differences in emergency medical services management of patients with myocardial infarction: Analysis of routinely collected data for over 110,000 patients" [Am Heart J (2021) 87-91].
    Am Heart J. 2021 Dec 24. pii: S0002-8703(21)00451.
    >> Share

  170. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
    Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
    Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
    >> Share

  171. SIDHU MS, Lyubarova R, Bangalore S, Bonaca MP, et al
    Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00478.
    >> Share

  172. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
    Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
    >> Share

  173. PASALA S, Cooper LB, Psotka MA, Sinha SS, et al
    The Influence of Heart Failure on Clinical and Economic Outcomes among Older Adult >/=75 Years of Age with Acute Myocardial Infarction.
    Am Heart J. 2021 Dec 16. pii: S0002-8703(21)00474.
    >> Share

  174. SIEGMUND AS, Pieper PG, Bilardo CM, Gordijn SJ, et al
    Cardiovascular Determinants of Impaired Placental Function in Women with Cardiac Dysfunction.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00473.
    >> Share

  175. ACQUAH I, Hagan K, Valero-Elizondo J, Javed Z, et al
    Delayed Medical Care due to Transportation Barriers Among Adults with Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00472.
    >> Share

  176. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    >> Share

  177. BHASIN S, Lincoff AM, Basaria S, Bauer DC, et al
    Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study.
    Am Heart J. 2021 Dec 3. pii: S0002-8703(21)00467.
    >> Share

  178. MONTOY JCC, Shen YC, Krumholz HM, Hsia RY, et al
    Association of STEMI regionalization of care with de facto NSTEMI regionalization.
    Am Heart J. 2021;242:1-5.
    >> Share

    November 2021
  179. AKHABUE E, Wong M, Mehta R, Isakova T, et al
    Fibroblast Growth Factor-23 and Subclinical Markers of Cardiac Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Am Heart J. 2021 Nov 30. pii: S0002-8703(21)00460.
    >> Share

  180. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    >> Share

  181. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    >> Share

  182. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
    Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
    Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
    >> Share

  183. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.
    >> Share

  184. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
    The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
    Am Heart J. 2021;241:92-100.
    >> Share

  185. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
    Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
    Am Heart J. 2021;241:101-107.
    >> Share

  186. POVSIC TJ, Henry TD, Ohman EM, Pepine CJ, et al
    Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
    Am Heart J. 2021;241:38-49.
    >> Share

    October 2021
  187. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
    Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
    >> Share

  188. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
    Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
    >> Share

  189. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    >> Share

  190. CHACIN-SUAREZ A, Grace SL, Anchique-Santos C, Supervia M, et al
    Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison.
    Am Heart J. 2021;240:16-27.
    >> Share

    September 2021
  191. PANKAYATSELVAN V, Mukamal KJ
    Influenza Vaccination Among Adults with Cardiovascular Disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019.
    Am Heart J. 2021 Sep 29. pii: S0002-8703(21)00233.
    >> Share

  192. CAINZOS-ACHIRICA M, Anugula D, Mszar R, Grandhi G, et al
    Rationale and Pathways Forward in the Implementation of Coronary Artery Calcium-Based Enrichment of Randomized Trials.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00235.
    >> Share

  193. SALAH HM, Khan Minhas AM, Khan MS, Khan SU, et al
    Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018.
    Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00238.
    >> Share

  194. YIN Y, Fang C, Jiang S, Wang J, et al
    In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging.
    Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00236.
    >> Share

    July 2021
  195. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    >> Share

    June 2021
  196. ABE M, Ozaki Y, Takahashi H, Ishii M, et al
    Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy.
    Am Heart J. 2021 Jun 23. pii: S0002-8703(21)00165.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016